Cosmetic oculofacial applications of botulinum toxin: A report by the American Academy of Ophthalmology

Ophthalmology

Volumn 112, Issue 6, 2005, Pages 1159-1167

  Kaltreider, Sara A ^a   Kennedy, Robert H ^a   Woog, John J ^a   Bradley, Elizabeth A ^a   Custer, Philip L ^a   Meyer, Dale R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN; BOTULINUM TOXIN A; MUSCLE RELAXANT AGENT;

BLEEDING; CLINICAL TRIAL; DIPLOPIA; DIZZINESS; DRUG SAFETY; ECCHYMOSIS; ECTROPION; EDEMA; ERYTHEMA; FLU LIKE SYNDROME; HEADACHE; HUMAN; INJECTION SITE REACTION; KERATOCONJUNCTIVITIS SICCA; NAUSEA; PHOTOPHOBIA; PHYSICIAN; PRIORITY JOURNAL; PRURITUS; PTOSIS; REVIEW; RHYTIDOPLASTY; SIDE EFFECT; STANDARDIZATION; STATISTICAL ANALYSIS; WRINKLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; CONTROLLED CLINICAL TRIAL; CUTANEOUS PARAMETERS; DRUG EFFECT; ESTHETIC SURGERY; EYELID; FACE MUSCLE; METHODOLOGY; OPHTHALMOLOGY; ORGANIZATION; RANDOMIZED CONTROLLED TRIAL; SAFETY; TREATMENT OUTCOME;

ACADEMIES AND INSTITUTES; BOTULINUM TOXIN TYPE A; COSMETIC TECHNIQUES; EYELIDS; FACIAL MUSCLES; HUMANS; NEUROMUSCULAR AGENTS; OPHTHALMOLOGY; RANDOMIZED CONTROLLED TRIALS; RHYTIDOPLASTY; SAFETY; SKIN AGING; TECHNOLOGY ASSESSMENT, BIOMEDICAL; TREATMENT OUTCOME;

EID: 20144365068     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2005.03.021     Document Type: Review

References (28)

1. A.B. Scott, A. Rosenbaum, C.C. Collins Pharmacologic weakening of extraocular muscles Invest Ophthalmol 12 1973 924 927
2. R.P. Clark, C.E. Berris Botulinum toxin a treatment for facial asymmetry caused by facial nerve paralysis Plast Reconstr Surg 84 1989 353 355
3. J. Carruthers, A. Carruthers Botulinum toxin (botox) chemodenervation for facial rejuvenation Facial Plast Surg Clin North Am 9 2001 197 204 vii
4. J. Carruthers, A. Carruthers BOTOX use in the mid and lower face and neck Semin Cutan Med Surg 20 2001 85 92
5. A. Carruthers, J. Carruthers Botulinum toxin type A history and current cosmetic use in the upper face Semin Cutan Med Surg 20 2001 71 84
6. J.D. Carruthers, N.J. Lowe, M.A. Menter Botox Glabellar Lines II Study Group Double-blind, placebo-controlled study of the safety and efficacy of botulinum toxin type A for patients with glabellar lines Plast Reconstr Surg 112 2003 1089 1098
7. J.A. Carruthers, N.J. Lowe, M.A. Menter BOTOX Glabellar Lines I Study Group A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines J Am Acad Dermatol 46 2002 840 849
8. N.J. Lowe, A. Maxwell, H. Harper Botulinum A exotoxin for glabellar folds a double-blind, placebo-controlled study with an electromyographic injection technique J Am Acad Dermatol 35 1996 569 572
9. M.S. Zimbler, J.B. Holds, M.S. Kokoska Effect of botulinum toxin pretreatment on laser resurfacing results a prospective, randomized, blinded trial Arch Facial Plast Surg 3 2001 165 169
10. H.G. Gassner, D.A. Sherris Addition of an anesthetic agent to enhance the predictability of the effects of botulinum toxin type A injections a randomized controlled study Mayo Clin Proc 75 2000 701 704
11. S.L. Matarasso Comparison of botulinum toxin types A and B a bilateral and double-blind randomized evaluation in the treatment of canthal rhytides Dermatol Surg 29 2003 7 13
12. N.J. Lowe, G. Lask, P. Yamauchi, D. Moore Bilateral, double-blind, randomized comparison of 3 doses of botulinum toxin type A and placebo in patients with crow's feet J Am Acad Dermatol 47 2002 834 840
13. T.C. Flynn, J.A. Carruthers, J.A. Carruthers Botulinum-A toxin treatment of the lower eyelid improves infraorbital rhytides and widens the eye Dermatol Surg 27 2001 703 708
14. T.B. West, T.S. Alster Effect of botulinum toxin type A on movement-associated rhytides following CO2 laser resurfacing Dermatol Surg 25 1999 259 261
15. A. Carruthers, J. Carruthers, J. Cohen A prospective, double-blind, randomized, parallel-group, dose-ranging study of botulinum toxin type A in female subjects with horizontal forehead rhytides Dermatol Surg 29 2003 461 467
16. A.S. Frankel, F.M. Kamer Chemical browlift Arch Otolaryngol Head Neck Surg 124 1998 321 323
17. M. Heckmann, G. Schon-Hupka Quantification of the efficacy of botulinum toxin type A by digital image analysis J Am Acad Dermatol 45 2001 508 514
18. G. Goodman Botulinum toxin for the correction of hyperkinetic facial lines Australas J Dermatol 39 1998 158 163
19. W. Muhlbauer, C. Holm Eyebrow asymmetry ways of correction Aesthetic Plast Surg 22 1998 366 371
20. J.M. Olver Botulinum toxin A treatment of overactive corrugator supercilii in thyroid eye disease Br J Ophthalmol 82 1998 528 533
21. E.A. Pribitkin, T.M. Greco, R.L. Goode, W.M. Keane Patient selection in the treatment of glabellar wrinkles with botulinum toxin type A injection Arch Otolaryngol Head Neck Surg 123 1997 321 326
22. K.Y. Ahn, M.Y. Park, D.H. Park, D.G. Han Botulinum toxin A for the treatment of facial hyperkinetic wrinkle lines in Koreans Plast Reconstr Surg 105 2000 778 784
23. M. Alam, K.A. Arndt, J.S. Dover Severe, intractable headache after injection with botulinum A exotoxin report of 5 cases J Am Acad Dermatol 46 2002 62 65
24. D.A. Ellis, A.K. Tan Cosmetic upper-facial rejuvenation with botulinum J Otolaryngol 26 1997 92 96
25. S.L. Matarasso, A. Matarasso Treatment guidelines for botulinum toxin type A for the periocular region and a report on partial upper lip ptosis following injections to the lateral canthal rhytids Plast Reconstr Surg 108 2001 208 214
26. D.M. Hexsel, A.T. De Almeida, M. Rutowitsch Multicenter, double-blind study of the efficacy of injections with botulinum toxin type A reconstituted up to six consecutive weeks before application Dermatol Surg 29 2003 523 529
27. P. Becker-Wegerich, L. Rauch, T. Ruzicka Botulinum toxin A in the therapy of mimic facial lines Clin Exp Dermatol 26 2001 619 630
28. D. Tarsy, N. Bhattacharyya, G. Borodic Myasthenia gravis after botulinum toxin A for Meige syndrome Movement Disord 15 2000 736 738